Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.42%
Monatliche Änderung
-18.98%
6 month change
+32.78%
Jahresänderung
+17.73%
Vorheriger Schlusskurs
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volumen
70
Märkte
Aktien
Gesundheitswesen
ZNTL
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
41.04 M
45.56 M
59.42 M
70.96 M
71.81 M
—
Valuation ratios
Enterprise value
2.1 B
3.77 B
1.18 B
1.11 B
183.69 M
372.27 M
Price to earnings ratio
—
-22.6
-4.61
-3.58
-1.3
-3.04
Price to sales ratio
—
239.22 K
19.49 K
1 162.1
3.19
14.47
Price to cash flow ratio
—
-23.29
-6.67
-5.03
-1.26
-3.36
Price to book ratio
—
3.31
0.67
2.39
0.64
0.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.32
0.35
0.44
0.53
0.39
0.35
Return on equity %
0.35
0.44
0.55
0.67
0.49
0.45
Return on invested capital %
222.76
444.81
540.5
477.87
396.7
875.44
Gross margin %
—
100
100
100
100
—
Operating margin %
—
1.44 M
405.87 K
33.28 K
283.57
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
1.06 M
422.87 K
32.47 K
245.96
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
12.07
7.98
7.98
7.16
7.32
30
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
0
0
0.14
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
3.61
3.1
3.18
2.4
1.87
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.49
6.11
2.16
6.05
16.53
Net current asset value per share
—
8.22
8.55
7.59
5.43
18.54
Tangible book value per share
—
25.29
30.75
6.63
4.74
16.18
Working capital per share
—
7.19
7.48
6.53
4.69
16.05
Book value per share
—
25.38
30.82
6.69
4.74
16.18
Nachrichten
CEO von Zentalis Pharma veräußert Aktien im Wert von 21.000 $
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma: CMO Bruns verkauft Aktien im Wert von rund 8.000 US-Dollar
Insider-Verkauf bei Zentalis Pharmaceuticals: PAO veräußert Aktien im Wert von 97.556 $
Zentalis Pharma CMO Bruns sells $7998 in stock
Großaktionär Walters Group investiert 7,7 Mio. US-Dollar in Zentalis Pharmaceuticals
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Leerink Partners senkt Kursziel für Zentalis Pharmaceuticals auf 2 US-Dollar/n
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting